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Abstract. The objective of this study was to test the inactivation efficiency of two different light-based treatments,
namely ultraviolet B (UVB) and ultraviolet C (UVC) irradiation, on Pseudomonas aeruginosa biofilms at different
growth stages (24, 48, and 72 h grown). In our experiments, a type of AlGaN light-emitting diodes (LEDs) was
used to deliver UV irradiation on the biofilms. The effectiveness of the UVB at 296 nm and UVC at 266 nm
irradiations was quantified by counting colony-forming units. The survival of less mature biofilms (24 h
grown) was studied as a function of UV-radiant exposure. All treatments were performed on three different bio-
logical replicates to test reproducibility. It was shown that UVB irradiation was significantly more effective than
UVC irradiation in inactivating P. aeruginosa biofilms. UVC irradiation induced insignificant inactivation on
mature biofilms. The fact that the UVB at 296 nm exists in daylight and has such disinfection ability on biofilms
provides perspectives for the treatment of infectious diseases. © The Authors. Published by SPIE under a Creative Commons
Attribution 3.0 Unported License. Distribution or reproduction of this work in whole or in part requires full attribution of the original publication, including its
DOI. [DOI: 10.1117/1.JBO.22.6.065004]
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1 Introduction
Biofilm-contaminated medical devices are believed to be a
common cause for hospital-acquired infections.1 Moreover,
biofilms are implicated in chronic infections, such as chronic
wounds and tissue filler-, implant-, and catheter-associated
infections.2 Traditionally microbial infections are treated by
antibiotics that either kill the microbe or inhibit the contami-
nated area from spreading.3 However, the problem with this
approach is that antibiotic resistance is developed.4 Furthermore,
biofilms exhibit greater tolerance to antibiotics and antimicro-
bial stressors than planktonic organisms of the same species.5
As a consequence, researchers have turned their interest toward
alternative disinfection approaches, including bacteriophages,6
bacteriocins,7 and light-based treatments.8 UV irradiation,9,10
photodynamic therapy,11,12 blue,13,14 and near-infrared light15,16
are all noninvasive methods and have been reported to have the
ability to inactivate microorganisms. Moreover, the expectation
that the bacteria will develop light-resistant genes is low.8 On the
other hand, light-based solutions demand effective light deliv-
ery. Thus, the potential applications are confined by penetration
depth of light to the region of interest. For this reason, branches
of medicine, such as dermatology and dentistry were the first to
adopt the technology due to easier optical access to the region of
interest.
In this work, the efficiencies of two different light-based dis-
infection treatments were tested, namely ultraviolet B (UVB)
and ultraviolet C (UVC) irradiation, on P. aeruginosa biofilms
at different growth stages. Their antibacterial action was studied
as a function of radiant exposure. The survival curves were mod-
eled using GInaFiT17 (Geeraerd and Van Impe Inactivation
Model Fitting Tool).
The disinfection ability of UV light-emitting diodes (LEDs)
could offer new possibilities for potential disinfection applica-
tions not only in terms of cleaning instruments, equipment, and
clinical surfaces but also in terms of potential treatments.
2 Materials and Methods
2.1 Ultraviolet Treatments
The UV LEDs that were used to deliver the irradiation to the
biofilms were purchased from Sensor Electronic Technology,
Inc. (SETi, Columbia, South Carolina; TO3 package, hemi-
spherical lens window). The diodes were operated in constant
current mode. The spectral power distribution of the LEDs is
shown in Fig. 1. The setup for performing the irradiations is
shown in Fig. 2. The irradiation of the UV-LEDs was measured
by an external optical probe (EOP-146, Instrument Systems
GmbH, Munich, Germany) and a monochromator. The spec-
trometer coupled to the monochromator was a SPECTRO 320
(D) Release 5 (Instrument Systems GmbH). Details about the
irradiation measurements protocol can be found in Barnkob
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et al.18 The irradiance delivered on the biofilms was also cross
confirmed with a portable radiometer (NIST-certified UV radi-
ometer); the distances the irradiance measurements were taken
(1.5 0.1 cm) were the same distances that the exposures were
conducted.
In all exposures, the distance between the LED and the bio-
film (circular entity with diameter 1.0 0.2 cm) was kept con-
stant at 1.5 0.2 cm (the error originates from the agar height in
the Petri dish). All biofilms, before and after treatments, were
stored in a UV-free environment. As a standard, all treatments
were performed on three different biological replicates to test the
reproducibility.
2.2 Biofilm Preparation
A cellulose nitrate membrane filter (pore size: 0.2-μm diameter:
25 mm, Whatman GmbH, Germany) was placed directly on the
agar plate. The plate and filter were dried for 30 min at 37°C
before the bacterial overnight (ON) culture was added in a single
spot (20-μL bacterial suspension) on the membrane filter. The
bacteria were spot inoculated onto the filter directly from the
ON culture. The P. aeruginosa used for the experiments was
obtained from the Pseudomonas Genetic Stock Center (strain
PAO119). The biofilms were grown on AB-trace glucose (0.5%)
(ABTG) plates and incubated for 24, 48, or 72 h at 37°C. A more
detailed description for the ON cultures and filter biofilms meth-
odology (“the micropore assay”) can be found in Bjarnsholt
et al.20 For a mature biofilm (either grown for 48 or 72 h) to
develop, the membrane filter containing the growing biofilm
was transferred to a fresh, dried ABTG plate every 24 h. In
this way, the fresh media available to the biofilm facilitated
growth.
2.3 Colony-Forming Unit Determination
Filters with the biofilms growing on top were transferred with
sterile forceps to a 15 mL Falcon tube containing 5 mL of saline
(0.9% NaCl). Samples were mixed for 15 s, degassed for 5 min,
and sonicated for 5 min in an ultrasonication bath to release the
bacteria from the filter. Sonication fluid was serial diluted from
10−1 to 10−8 and 20 μL of all dilutions were spotted once on LB
agar plates followed by ON incubation at 37°C. The colony-
forming units (CFUs) were counted after 24 h of incubation
in the dark at 37°C. Note that CFUs are per initial volume
and were calculated with the weighted average method.21 An
example of how the CFUs looked after counting is shown in
Fig. 3. Control samples, i.e., biofilms that were not exposed
to UV irradiation, were plated every hour and included in the
study as a reference for growth.
2.4 Experimental Design
The objective was to determine how the selected UV region,
namely UVB versus UVC, and radiant exposure will influence
the viability of P. aeruginosa biofilms. The radiant exposure for
Fig. 1 Spectral irradiance of the UVB (black curve) and UVC LEDs
(red curve) used for the irradiation of the biofilms.
Fig. 2 Schematic sketch of the UV irradiation setup. The agar plate carrying the biofilm is illuminated by
the UV LED in a UV-opaque box.
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less mature biofilms was investigated in the range (approxi-
mately) from 70 to 10;000 J∕m2. The irradiance was varied
between 18.6 0.2 W∕m2 and 108 11 W∕m2 with the UVC
diode. For the UVB diode, the irradiance was varied between
1 0.1 W∕m2 and 14.8 0.2 W∕m2. In all treatments, the
exposure time was <12 min.
Mature biofilms (48 and 72 h grown) were treated with radi-
ant exposure around 20;000 J∕m2, and effectiveness of the treat-
ments (UVB and UVC) was compared to control (no treatment)
and less mature biofilms (24 h grown). For testing the effect of
maturity on the effectiveness of the treatments, the exposures
were performed on three independent biological replicates
and executed twice (two technical replicates). Pairwise t-tests
were used to detect inactivation efficiency differences among
treatments (20;000 J∕m2) for the different growth stages.
2.5 Modeling of Biofilm Survival
GInaFiT17 a freeware add-in for Microsoft® Excel, was used to
model the biofilm survival curves. Modeling of bacterial sur-
vival can provide some insight into the mechanisms behind inac-
tivation and provide guidelines for prediction of required doses
to succeed a specific level of inactivation. Microbial inactivation
has traditionally been described by first-order kinetics. The
GInaFiT tool supports testing of nine types of microbial survival
models, and five statistical measures (i.e., sum of squared errors,
mean sum of squared errors and its root, R2, and adjusted R2) are
provided to monitor the best fit (f function). Here, a choice of
five suitable models22–26 was applied to the mean values (from
three technical replicates) of log survival obtained from one bio-
logical replicate (replicate 3)
EQ-TARGET;temp:intralink-;e001;63;158
Log survival ¼ Log Ntreated
Ncontrol
¼ −ðLogNcontrol − LogNtreatedÞ
¼ −Log inactivation ¼ fðdoseÞ; (1)
where Ntreated is the number of CFUs after a UV-radiant expo-
sure (J∕m2) is delivered to the biofilm and Ncontrol is the number
of CFUs on the controls (not UV exposed). When zero counts
are observed in Ntreated, the log survival is not calculated.
3 Results
3.1 Ultraviolet B Inactivation Rate (Less Mature
Biofilms)
The log survival values of P. aeruginosa biofilms, after being
exposed to UVB irradiation with a central wavelength at
296 nm, as a function of UV-radiant exposure (dose) are pre-
sented in Fig. 4. Most models demonstrated a good fit to the
experimental data (R2 ≥ 0.9), except the linear model.22 The
“biphasic” model26 fit best to the data (Fig. 4). However, this
model requests minimal 10 points to ensure validity. The stat-
istical measures of the models applied are presented in Table 1.
If we use the concept of reliability engineering, the reliable dose
dR
27 (dose needed to reduce number of microorganisms by a
factor of 10) is calculated to be 638 J∕m2 (from the “Weibull
model,” the hazard rate was found to be α ¼ 54.86 and the
shape parameter β ¼ 0.34).
The GInaFiT tool predicts that the required dose for achiev-
ing a 4-log reduction in the CFUs is 1900 J∕m2, in accordance
with the experimentally observed value (at 2000 J∕m2, 4.1-log
reduction). No CFU was observed when a dose of 10;000 J∕m2
was delivered to the biofilm (independently of biological repli-
cate), indicating total inactivation; potential presence of bacteria
could not be detected since the treatment challenged the detec-
tion limit of the method used (drop plate technique28), nor were
CFUs observed for biological replicate two, already at a radiant
exposure of 7200 J∕m2.
3.2 Ultraviolet C Inactivation Rate (Less Mature
Biofilms)
The antibacterial action of UVC irradiation, with central wave-
length at 266 nm is shown in Fig. 5 with a “Weibull model fit.24”
With α ¼ 9870 and β ¼ 0.44, the reliable dose dR27 was calcu-
lated to be 65;722 J∕m2. The statistical measures of the models
applied are shown in Table 1. The GInaFiT tool in this case was
Fig. 4 UVB-radiant exposure-dependent antibacterial action on P.
aeruginosa biofilms. “Biphasic model” fit to the experimental data.
This model requires a minimal 10 points to ensure validity. The
error bars for biological replicate 3 represent propagation of uncer-
tainty for the function of log survival, originating from three technical
replicates.
Fig. 3 Typical picture of a labeled agar plate after regrowth (control
sample). At higher dilutions, countable and well-separated CFUs are
formed, as indicated by the black circle. The yellowish spots are
the bacterial colonies, the back spots are the marks made by the tech-
nician (at the other side of the plate) while counting. The next aggre-
gation of colonies (move counterclockwise) is from one order
lower dilution; and the colonies (yellowish spots) are occasionally
overlapping.
Journal of Biomedical Optics 065004-3 June 2017 • Vol. 22(6)
Argyraki et al.: Inactivation of Pseudomonas aeruginosa biofilm. . .
Downloaded From: http://biomedicaloptics.spiedigitallibrary.org/ on 07/20/2017 Terms of Use: http://spiedigitallibrary.org/ss/termsofuse.aspx
unable to predict the required dose for achieving a 4-log reduc-
tion (maximum log reduction achieved experimentally was 1).
3.3 Mature Biofilms
The effect of the growth stage of the biofilm to the observed
efficacy of the applied treatments is summarized in Fig. 6.
No inactivation effect was observed with UVC (radiant exposure
around 20;000 J∕m2) on 48 h mature biofilms; CFU counts
were similar to the nontreated samples. Therefore, the treatment
was not attempted on biofilms grown for 72 h. Only a modest
inactivation was achieved on the less mature biofilms around 1-
log reduction (0.8 0.3 log reductions). To the contrary, UVB
(radiant exposure around 20;000 J∕m2) was able to inactivate
effectively mature biofilms grown for 48 h (3.2 1.3 log reduc-
tion) and for 72 h (2.9 0.7 log reduction). However, the effi-
ciency of inactivation decreased with maturity from zero counts
for less mature biofilms to around 3-log reduction for mature
biofilms. It is interesting to observe that the log reduction
achieved by the UVB treatment varies when the biofilms are
mature but are “straightforward” for the less mature biofilms.
According to the pairwise t-tests, there was a significant increase
in counts for the control from less mature to mature biofilms
(p ¼ 0.003). UVB treatment was significantly more effective
than UVC, both for biofilms grown for 24 and 48 h (p ≤ 0.004).
The UVB treatment was equally efficient for killing 48 and 72 h
mature biofilms (p ¼ 0.6).
3.4 Transmission Properties of Biofilms in the
Ultraviolet Region
Transmission properties of biofilms in the UV region were mea-
sured with a Cary 50 spectrophotometer. The membrane filters
on which the original biofilms were grown were opaque in the
UV region. Therefore, biofilms were grown on (UV transparent)
quartz surfaces (three samples). To grow these biofilms, quartz
surfaces were embedded in bacterial culture for 28 h. It cannot
be expected that a biofilm grown on quartz will attain the same
structure, thickness, and properties as a biofilm grown on a
membrane filter. Moreover, the biofilm thickness is not expected
to be the same over the whole quartz surface, confirmed by
observation of the samples by bare eye. The thickness variation
of the biofilm grown at different locations on one quartz plate
(“biofilm spot”) is attributed to the biological aspects of biofilm
formation. Therefore, large variation for the absolute values
of the transmission was expected; the location on the biofilm
where the transmission measurement was taking place was not
controllable.
Table 1 Statistical measures of the models applied to the experimental data for log reduction of P. aeruginosa by UVB (and UVC). In cases where
modeling was not applicable, the indication NA is registered.
Fitted model MSE RMSE R2 Adjusted R2 SSE D 4 log
Log-linear 1.6 (0.03) 1.28 (0.16) 0.69 (0.84) 0.63 (0.80) 9.84 (0.13) 8700 (NA)
Weibull 0.60 (0.01) 0.78 (0.1) 0.90 (0.95) 0.87 (0.92) 2.99 (0.04) 3300 (NA)
Biphasic 0.01 (0.01) 0.09 (0.08) 0.9989 (0.98) 0.9980 (0.95) 0.04 (0.02) 1900 (NA)
Log + tail 0.014 (0.02) 0.12 (0.12) 0.9978 (0.92) 0.9970 (0.88) 0.07 (0.06) 1900 (NA)
Albert (Weibull and tail) 0.017 (NA) 0.13 (NA) 0.9978 (NA) 0.9960 (NA) 0.07 (NA) 1900 (NA)
Fig. 5 UVC-radiant exposure-dependent antibacterial action on P.
aeruginosa biofilms (experimental data and Weibull fit). The error
bars for biological replicate 3 represent propagation of uncertainty
for the function of log survival, originating from three technical
replicates.
Fig. 6 CFU regrowth after different treatments are applied (UVB
20,000, UVC 20;000 J∕m2, and control) on biofilms at different matu-
rity stages (24, 48, and 72 h grown). The error bars represent the stan-
dard deviation. No counts were observed for all replicates after the
UVB treatment was applied on 24 h grown biofilms. The UVC treat-
ment was not performed on the 72 h grown biofilms since only modest
inactivation was observed for biofilms grown for 48 h (missing green
column for the UVC treatment). CFUs are per initial volume.
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The transmission properties of biofilms grown on quartz
(Fig. 7) and, more specifically, the ratio of transmission proper-
ties at different wavelengths could assist in obtaining a better
understanding of the UV wavelength-dependent penetration
ability into a thin layer of bacteria existing in a “biofilm state.”
It was observed that on average (three different spots, each on
a different biofilm quartz sample, were measured) 10% less UV
light was transmitted at a wavelength of 266 nm than at 296 nm,
the transmission curve slope was found to be 0.33 0.07. In the
case of biofilm location 2 (obviously the thickest among the
“biofilm spots”measured), only 37% was transmitted at a wave-
length of 266 nm (Fig. 7).
Therefore, it is believed that, in the case of the biofilms
grown on filters, which were much thicker, the UVC irradiation
did not penetrate through the whole biofilm volume.
4 Discussion
To achieve no regrowth after treatment with UV irradiation, it is
assumed that the penetration depth of the UV wavelength should
be such that the dose arriving at the deepest layer of biofilm
equals the lethal dose 100 (LD100, defined as the dose resulting
in 100% inactivation). It is expected that the effectiveness of the
UV treatment will be strongly correlated to the thickness as well
as the opaqueness of the biofilm. If for some reason (e.g.,
increased thickness) the delivered dose at the deepest layer is
reduced, it is expected that the growth observed can be increased
by several orders of magnitude, due to bacterial survival. The
typical thickness for both less mature and mature biofilms is
∼200 μm or more. It is probable that the thickness and opaque-
ness of the biofilms vary significantly among different ON cul-
tures and even among technical replicates. Therefore, variance
of the inactivation effect, achieved by UVB-effective treatments,
should be expected to be observed, depending on the biofilm
properties. This was confirmed by the experimental process
(Figs. 3–5). For ineffective UV treatments, the variance should
be masked since insignificant inactivation effects are induced in
all replicates. To our knowledge, the ability to eliminate a bio-
film with UVB LEDs (narrowband spectral power distribution)
more effectively than UVC has not previously been reported.
If in the future, UV treatments are used for clinical purposes
should not exceed 15 min for convenience. All treatments in
the present paper did not exceed 12 min, despite the power
constraints existing at the moment for AlGaN UV LEDs.29
The term inactivation is used in a broader context that includes
both possibilities of either killing the biofilm or inactivating it.
Modeling of the radiant exposure dependent killing of the P.
aeruginosa biofilms with UVC and UVB light showed that a
log-linear model (based on first-order kinetics) failed to fit
the experimental data (in the tested range for radiant exposure,
namely from 70 to 10;000 J∕m2) and failed to provide a satis-
factory estimate for the required radiant exposure for achieving a
4-log CFU reduction. On the contrary, more complex models
that take into account a “shift of behavior” (Weibull, biphasic,
logþtail, Albert) for a subgroup of bacteria succeeded in fitting
the experimental data (R2 ≥ 0.9). Moreover, the “Weibull
model” was adequate for giving a rough estimation/prediction
(correct order of magnitude) of the reliable dose dR, for both
UVB and UVC treatments. Weibull models have been reported
to successfully predict inactivation of Escherichia coli and
Salmonella enterica after exposure to ozone or pulsed light
(100 to 1100 nm).30 Finally, β values were <1 for both UVB
and UVC treatments, meaning that there are some persistent
bacteria in the biofilm that have less probability of being killed,
perhaps because they adapt to the irradiation or because they are
not as affected, e.g., due to limited penetration depth of light to
the biofilm’s deepest layers and/or due to the shielding effect of
the extracellular polymeric substances.
5 Conclusion and Outlook
Different UV treatments were applied on P. aeruginosa bio-
films, namely UVB irradiation and UVC irradiation, and the
effect of the treatments on the ability of the biofilm to regrow
was studied quantitatively.
For biofilms grown for 24 h, it was shown that the biofilm
survival could not be described and predicted sufficiently by
first-order kinetics (in the tested range for radiant exposure,
namely from 70 to 10;000 J∕m2). The “Weibull model” was
successful in giving a prediction of the reliable dose dR, for
the UVB treatment. From the survival curves (tested in the
range from 70 to 10;000 J∕m2), it was concluded that UVB irra-
diation is much more efficient in inactivating P. aeruginosa bio-
film (24 h grown) than UVC.
Moreover, it was demonstrated that the efficacy of the UVB
treatment (20;000 J∕m2) drops drastically when performed on
more mature biofilms. While total inactivation was observed
for 24 h grown biofilms, only a 3-log reduction was achieved
(on average) on mature biofilms (48 and 72 h grown). The
UVB treatment was equally efficient for killing 48 and 72 h
mature biofilms (p ¼ 0.6). Furthermore, the success of the
UVB treatment varied when the biofilms were mature, but it
was “straightforward” for less mature biofilms (no counts
observed in all cases). The UVC treatment (20;000 J∕m2)
could not be considered a successful treatment independently
of the maturity stage of the biofilm; inactivation did not exceed
1-log even at 20;000 J∕m2. Nontreated samples (control) exhib-
ited a slight increase in counts with maturity (p ¼ 0.003).
The UVB treatment (20;000 J∕m2) was significantly more
effective than UVC (20;000 J∕m2), both for biofilms grown
for 24 and 48 h (p ≤ 0.004).
Since the effectiveness of treatments involving UV irradia-
tion clearly depends on the thickness/opaqueness of the biofilm,
it is crucial to investigate in the future the correlations among the
variables: biofilm thickness, biofilm opaqueness for various UV
wavelengths, biofilm maturity, species of bacteria present in the
Fig. 7 Transmission spectra of biofilms grown on quartz under the
exact same conditions. It is observed that on average 10% more
UV light is transmitted at a wavelength of 296 nm than at 266 nm.
Only 37% is transmitted at 266 nm for biofilm location 2.
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biofilm, and inactivation efficiency of UV wavelengths. The fact
that UVB irradiation (wavelength of 296 nm), which exists in
daylight, has such disinfection ability on biofilms reveals new
aspects for direct exposure to sunlight and frames some prospect
for indoor illumination using UV-transparent windows. The bio-
film inactivation ability of LEDs in the UVB range offers new
possibilities for applications not only in terms of disinfecting
instruments but also for treatment of infectious diseases.
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